Search International and National Patent Collections

1. (WO2017153850) PERHEXILINE DOSING REGIMENS FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY

Pub. No.:    WO/2017/153850    International Application No.:    PCT/IB2017/000550
Publication Date: Fri Sep 15 01:59:59 CEST 2017 International Filing Date: Wed Mar 08 00:59:59 CET 2017
IPC: A61K 31/4458
A61P 9/00
A61P 9/02
A61P 9/04
Applicants: HEART METABOLICS LIMITED
Inventors: MIDEI, Mark
SHALWITZ, Robert, Alan
Title: PERHEXILINE DOSING REGIMENS FOR USE IN THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
Abstract:
The present invention provides perhexiline, or a pharmaceutically acceptable salt thereof, for use in therapeutic methods for treating hypertrophic cardiomyopathy with preserved left ventricular function.